membran
protein
ion
channel
transport
receptor
secret
protein
essenti
cellular
activ
nlink
glycosyl
involv
stabil
function
protein
occur
asn
residu
sever
organ
profil
nglycan
determin
comprehens
analys
nevertheless
cochlea
mammalian
inner
ear
tini
organ
mediat
hear
yet
examin
focus
stria
vasculari
epitheliallik
tissu
cochlea
characteris
nglycan
liquid
chromatographi
mass
spectrometri
hypervascular
tissu
express
sever
ion
transport
channel
control
electrochem
balanc
cochlea
also
harbour
differ
transport
receptor
maintain
structur
activ
organ
seventynin
nlink
glycan
identifi
rat
stria
vasculari
among
glycan
complet
structur
determin
speci
partial
glycosid
linkag
pattern
full
profil
monosaccharid
composit
identifi
process
characteris
sever
sialyl
glycan
subject
sequenti
two
differ
alkylamid
reaction
derivatis
help
distinguish
sialyl
isom
mass
spectrometri
data
acceler
elucid
molecular
architectur
cochlea
cellular
tissu
function
precis
dynam
control
varieti
membraneintegr
protein
receptor
ion
channel
transport
protein
glycosyl
posttranscript
modif
also
occur
major
secret
protein
mediat
crosstalk
among
cell
glycosyl
affect
asn
residu
nglycan
serthr
residu
oglycan
recent
studi
highlight
role
differ
nglycan
process
relat
protein
stabil
traffick
also
modul
action
membran
protein
therefor
characteris
glycan
type
express
tissu
organ
crucial
elucid
molecular
architectur
underli
vital
phenomena
variou
organ
although
structur
nglycan
serum
sever
organ
includ
brain
lung
kidney
comprehens
analys
cochlea
mammalian
inner
ear
small
organ
millimetr
size
yet
suffici
profil
cochlea
stria
vasculari
epitheliallik
tissu
compos
margin
intermedi
basal
cell
contain
numer
capillari
therefor
carri
varieti
substanc
includ
hormon
metabolit
glucos
even
extern
appli
drug
blood
tissu
action
like
mediat
consider
number
organ
transport
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
http
besid
receptor
growth
factor
hormon
express
strial
cell
strial
k
channel
k
uptak
transport
maintain
high
k
mm
highli
posit
potenti
mv
extracellular
fluid
endolymph
electrochem
milieu
contribut
mainten
hear
fig
endolymphat
properti
volum
osmolar
ph
may
balanc
varieti
ion
channel
transport
stria
addit
margin
cell
seem
secret
protein
type
involv
develop
cochlea
overal
plausibl
strial
membran
protein
network
describ
collect
crucial
cochlear
function
present
studi
focus
stria
vasculari
profil
structur
nglycan
potenti
regul
activ
membran
secret
protein
method
combin
three
high
perform
liquid
chromatographi
hplc
type
differ
mode
multistag
mass
spectrometri
ms
n
identifi
differ
nglycan
speci
characteris
structur
verif
purif
stria
vasculari
dissoci
cochlea
stria
vasculari
enrich
capillari
tightli
attach
neighbour
tissu
spiral
ligament
later
cochlear
wall
fig
first
perfus
rat
system
salin
remov
blood
stria
vasculari
care
isol
tissu
later
wall
fig
see
also
method
nevertheless
concern
contamin
ligament
sampl
therefor
decid
evalu
puriti
sampl
totalrna
sampl
extract
isol
stria
vasculari
spiral
ligament
cochlea
rat
independ
analys
quantit
pcr
qpcr
primer
four
gene
encod
protein
specif
tissu
fig
seri
assay
repeat
three
time
differ
batch
cochlea
stria
vasculari
separ
endolymph
spiral
ligament
margin
basal
cell
respect
fig
qpcr
assay
fig
show
mrna
cl
channel
barttin
bsnd
exclus
express
margin
cell
abund
sampl
stria
moder
detect
ligament
similar
result
obtain
primer
specif
claudin
compon
tight
junction
strand
basal
cell
next
perform
assay
primer
k
cl
cotransport
transcript
factor
present
ligament
absent
stria
vasculari
amount
mrna
two
gene
neglig
sampl
stria
well
detect
ligament
tendenc
observ
three
seri
experi
fig
observ
describ
confirm
puriti
strial
sampl
also
reliabl
isol
techniqu
detect
characteris
glycan
stria
vasculari
next
characteris
profil
glycan
stria
vasculari
strial
tissu
dissoci
cochlea
rat
combin
one
batch
sampl
lyophilis
chemic
treat
accord
process
describ
method
section
follow
workflow
carri
multipl
method
shown
fig
isol
later
cochlear
wall
assay
primer
gene
encod
k
cl
cotransport
type
exclus
express
sl
barttin
claudin
specif
stv
use
quantit
data
n
collect
refer
intern
gene
glyceraldehyd
dehydrogenas
gapdh
averag
standard
error
p
valu
determin
twotail
student
test
also
shown
scientif
report
http
first
step
glycan
obtain
stria
vasculari
sequenti
fraction
three
differ
hplc
type
describ
orang
box
upper
left
elut
time
record
reversedphas
size
fraction
hplc
repres
r
valu
r
stria
stria
respect
blue
box
parallel
origin
sampl
extract
via
reversedphas
hplc
analys
posit
ion
mode
lcesim
ms
green
box
upper
right
spectra
provid
monosaccharid
composit
linkag
pattern
basi
data
hplc
analys
standard
glycan
empir
addit
rule
predict
set
r
std
std
valu
r
calc
calc
valu
glycan
pink
box
comparison
inform
valu
r
stria
stria
determin
structur
glycan
speci
deepbluefil
ellips
glycan
whose
structur
complet
determin
procedur
palebluefil
ellips
next
subject
salsa
posit
ion
mode
maldim
darkpurpl
box
experi
reveal
sialyl
linkag
pattern
number
strial
glycan
extract
characteris
method
illustr
fig
seri
experi
crude
pyridylamin
pa
glycan
sampl
initi
subject
diethylaminoethyl
deae
anion
exchang
hplc
fig
method
fraction
nglycan
accord
number
attach
sialic
acid
residu
shown
fig
stria
vasculari
nonsial
glycan
n
abund
smaller
amount
monoand
disial
glycan
class
respect
also
detect
sampl
care
observ
unveil
weak
signific
signal
triand
tetrasialyl
class
respect
peak
n
signal
stem
primarili
nonglycan
materi
persist
sampl
process
five
fraction
n
separ
collect
assay
reversedphas
hplc
evalu
hydrophob
sampl
fig
numer
peak
obtain
assay
context
eluat
within
initi
min
like
contain
chemic
reagent
includ
pyridylamin
deriv
therefor
omit
analys
measur
area
individu
peak
found
fifth
fraction
nonsial
class
abund
speci
basi
observ
fraction
whose
area
exceed
fraction
assum
signific
accord
criterion
reevalu
data
obtain
reversedphas
hplc
fig
consequ
fraction
class
n
fraction
class
fraction
class
fraction
class
eight
fraction
class
collect
present
fig
total
fraction
see
also
fig
fraction
subject
one
one
size
fraction
hplc
analys
molecular
size
sampl
fig
raw
chromatogram
see
supplementari
fig
fraction
separ
procedur
compos
sole
glycan
type
area
individu
peak
determin
abund
speci
deriv
fraction
extract
reversedphas
hplc
product
size
fraction
hplc
fraction
whose
area
exceed
fraction
assum
signific
note
case
fraction
separ
reversedphas
hplc
multipl
peak
obtain
analysi
size
fraction
hplc
product
subnumb
refer
elut
time
tabl
supplementari
fig
tabl
consequ
least
glycan
speci
isol
strial
sampl
fig
supplementari
fig
glycan
subject
liquid
chromatographi
posit
ion
mode
electrospray
ionis
mass
spectrometri
lcesim
ms
analys
fig
former
origin
sampl
extract
reversedphas
hplc
analys
multipl
peak
show
differ
glycan
type
detect
spectra
mani
case
supplementari
fig
elut
profil
product
size
fraction
hplc
enabl
us
roughli
predict
molecular
mass
elut
glycan
basi
inform
among
fraction
obtain
ms
analysi
one
repres
aforement
glycan
select
examin
ms
supplementari
fig
seri
experi
reveal
glycan
reduc
end
consist
man
glcnac
core
structur
nglycan
tabl
supplementari
tabl
addit
identifi
man
glcnac
monofucosyl
deriv
also
categoris
nlink
type
tabl
supplementari
tabl
nglycan
subject
analys
fig
hand
glycan
contain
man
glcnac
man
glcnac
monofucosyl
deriv
characteris
follow
supplementari
fig
tabl
four
glycan
found
bear
reduc
end
compos
nacetylgalactosamin
therefor
manifest
olink
type
five
speci
like
degrad
product
origin
glycan
remaind
molecular
mass
predict
signal
size
fraction
hplc
could
explain
ms
data
gener
glycan
analys
lcesim
ms
spectra
provid
monosaccharid
composit
partial
glycosid
linkag
pattern
inform
occas
allow
us
predict
multipl
structur
type
glycan
next
determin
detail
profil
nlink
glycan
obtain
stria
vasculari
attempt
use
r
valu
fig
index
stem
measur
elut
time
glycan
reversedphas
hplc
size
fraction
hplc
respect
see
method
addit
standard
glycan
avail
commerci
resourc
major
analys
glycan
palebluefil
ellips
nevertheless
characteris
sialyl
linkag
requir
seri
complic
analys
consist
salsa
neg
ion
mode
maldim
n
palepurpl
box
deae
diethylaminoethyl
hplc
high
perform
liquid
chromatographi
lcesi
liquid
chromatographi
electrospray
ionis
ms
mass
spectrometri
r
std
r
valu
standard
glycan
std
valu
standard
glycan
r
calc
calcul
r
valu
calc
calcul
valu
salsa
sialicacidlinkagespecif
alkylamid
maldi
matrixassist
laser
desorptionionis
b
number
strial
glycan
extract
characteris
seri
method
describ
method
shown
left
side
glycan
collect
reversedphas
hplc
speci
mark
singl
hash
tag
detect
fraction
whose
peak
area
less
fraction
subsequ
hplc
chromatogram
therefor
exclud
assay
see
text
glycan
indic
doubl
hash
tag
like
olinkedtyp
nonspecif
moieti
see
text
group
highlight
deep
blue
glycan
whose
structur
determin
perfectli
wherea
group
colour
pale
blue
consist
glycan
whose
partial
linkag
assign
temporarili
whose
linkag
complet
clarifi
analys
summari
structur
strial
nglycan
total
profil
indic
black
bar
detail
experi
speci
describ
main
text
sialyl
speci
glycosid
linkag
inaccess
analys
use
r
valu
speci
initi
identifi
singl
sialyl
glycan
later
found
addit
sialyl
linkag
isom
tabl
valu
proceed
follow
four
step
nglycan
stria
vasculari
firstli
among
standard
glycan
speci
structur
ident
predict
one
multipl
structur
strial
glycan
identifi
secondli
r
valu
obtain
hplc
data
strial
glycan
r
stria
stria
see
compar
set
r
std
std
valu
standard
glycan
assign
first
step
thirdli
error
factor
error
r
std
error
std
valu
strial
glycan
correspond
standard
glycan
calcul
mean
formula
final
assign
standard
glycan
provid
error
factor
strial
glycan
accord
criteria
structur
strial
glycan
determin
present
tabl
supplementari
tabl
see
also
fig
supplementari
tabl
nevertheless
among
glycan
assign
neuac
gal
glcnac
man
fucglcnac
may
correct
inform
standard
glycan
two
sialyl
residu
limit
next
rest
strial
nlink
glycan
speci
see
fig
analys
via
follow
four
step
fig
firstli
even
glycan
composit
partial
linkag
pattern
determin
numer
peak
within
initi
min
like
contain
chemic
reagent
includ
pyridylamin
deriv
basi
data
extract
one
multipl
constitu
could
also
identifi
librari
standard
glycan
see
supplementari
tabl
secondli
r
std
std
valu
assign
constitu
combin
partial
elut
time
remain
residu
index
valu
deriv
obtain
type
linkag
pattern
residu
accord
empir
addit
rule
collect
two
process
could
predict
structur
strial
glycan
also
calcul
r
valu
ie
r
calc
calc
respect
furthermor
case
multipl
linkag
pattern
predict
one
strial
glycan
therefor
differ
set
r
calc
calc
valu
avail
thirdli
error
factor
error
r
calc
error
calc
r
valu
strial
glycan
ie
aforement
r
stria
stria
valu
set
r
calc
calc
valu
obtain
via
follow
equat
final
conclud
candid
show
two
error
factor
correspond
strial
glycan
seri
assay
determin
structur
strial
glycan
fig
tabl
supplementari
tabl
strial
glycan
remain
characteris
due
lack
partial
elut
time
constitu
fig
tabl
supplementari
tabl
context
although
clear
nonreduc
end
consist
nacetylhexosamin
whether
end
glcnac
galnac
uncertain
localis
galactos
nonreduc
end
could
determin
speci
mannos
residu
acetyl
modif
ordinarili
never
detect
organ
present
studi
like
artifici
take
place
renacetyl
process
liber
strial
glycan
see
method
neither
r
valu
acetyl
standard
glycan
empir
addit
rule
acetyl
avail
structur
three
glycan
mention
elus
strial
glycan
speci
speci
except
sialyl
also
contain
linkag
whose
elut
time
unknown
nevertheless
glycan
speci
mention
assign
neuac
gal
glcnac
man
fucglcnac
next
subject
profil
sialyl
linkag
pattern
fig
first
step
origin
reversedphas
hplc
fraction
contain
glycan
alkylamid
isopropylamin
ipa
thereaft
methylamin
process
ipa
bind
specif
right
panel
depict
signal
analys
ms
mode
subsequ
spectra
symbol
notat
peak
indic
composit
linkag
pattern
product
annot
structur
glycan
neuacgalglcnacman
glcnac
also
shown
left
panel
c
comparison
r
valu
obtain
analys
strial
glycan
three
differ
hplc
r
stria
stria
speci
standard
glycan
r
std
std
supplementari
tabl
sialic
acid
wherea
attach
sialic
acid
sampl
analys
matrixassist
laser
desorptionionis
quadrupol
ion
trap
timeofflight
mass
spectrometri
maldiqittof
ms
posit
ion
mode
derivatis
ipa
increas
molecular
mass
glycan
da
da
respect
compar
mass
determin
lcesim
combin
sialicacidlinkagespecif
alkylamid
salsa
mass
spectrometri
reveal
speci
separ
sole
glycan
via
three
differ
hplc
compos
two
glycan
type
one
contain
two
sialic
acid
residu
sialic
acid
residu
ie
sialic
acid
residu
two
sialic
acid
residu
ie
fig
tabl
supplementari
fig
tabl
also
case
speci
refer
tabl
supplementari
fig
tabl
detect
two
addit
speci
nlink
glycan
type
total
list
librari
stria
vasculari
fig
tabl
supplementari
tabl
furthermor
method
use
salsa
posit
ion
mode
maldiqittof
ms
indic
speci
sialic
acid
residu
two
sialic
acid
residu
although
three
linkag
shown
analys
r
std
std
valu
ie
neuac
gal
glcnac
man
fucglcnac
supplementari
tabl
observ
also
indic
initi
determin
structur
invalid
context
linkag
pattern
three
antenna
structur
contain
sialic
acid
core
structur
becam
uncertain
tabl
supplementari
tabl
final
characteris
structur
glycan
illustr
tabl
supplementari
tabl
see
also
supplementari
fig
tabl
summari
stria
vasculari
identifi
complet
structur
nlink
glycan
assign
partial
structur
along
full
profil
monosaccharid
composit
speci
fig
tabl
supplementari
tabl
speci
belong
latter
categori
molecular
mass
determin
posit
ion
mode
maldiqittof
ms
salsa
differ
da
molecular
mass
indic
combin
lcesim
ms
supplementari
fig
tabl
mark
inconsist
explain
effect
alkylamid
three
sialic
acid
residu
accordingli
derivatis
sampl
next
profil
neg
ion
mode
malditofm
n
describ
also
see
fig
exampl
structur
analysi
strial
nglycan
case
analysi
glycan
r
valu
reveal
linkag
pattern
address
mass
spectrometri
alon
repres
case
speci
characteris
lcesim
ms
analys
r
std
std
valu
fig
see
fig
differ
structur
two
strial
nglycan
limit
linkag
pattern
singl
sialic
acid
residu
tabl
supplementari
tabl
ms
spectrum
speci
detect
peak
mz
h
fig
glycan
separ
ms
tabl
observ
impli
speci
neuacgalglcnacman
glcnac
stage
remain
uncertain
whether
glycan
sialic
acid
residu
contain
sialic
acid
residu
predict
also
case
speci
fig
r
std
std
valu
respect
wherea
respect
supplementari
tabl
set
valu
compar
r
stria
stria
valu
two
strial
glycan
fig
calcul
error
r
std
std
valu
use
equat
aforement
criterion
reveal
speci
respect
shown
fig
see
also
tabl
supplementari
tabl
next
exampl
strial
glycan
whose
structur
characteris
r
calc
calc
valu
fig
illustr
fig
tabl
comparison
pair
valu
r
stria
stria
valu
indic
none
set
error
r
std
std
valu
satisfi
criterion
depict
fig
see
equat
assign
strial
glycan
obtain
r
calc
calc
valu
via
equat
lack
r
std
std
valu
detail
see
fig
basi
calcul
error
r
calc
calc
valu
aforement
criterion
speci
potenti
fig
experi
shown
fig
salsa
derivatis
necessari
clarifi
sialyl
linkag
see
fig
speci
initi
found
possess
two
sialic
acid
residu
hplc
assay
fig
appear
signal
mz
h
lcesim
spectra
fig
parent
ion
next
separ
ms
analysi
six
major
moieti
detect
signal
mz
tabl
observ
predict
neuac
gal
glcnac
man
fucglcnac
structur
glycan
situat
linkag
pattern
three
nacetylglucosamin
residu
antenna
structur
two
mannos
residu
core
structur
remain
obscur
fig
supplementari
tabl
moreov
two
sialic
acid
residu
bind
one
two
galactos
residu
antenna
structur
unresolv
issu
stem
unavail
r
calc
calc
valu
owe
lack
partial
elut
time
relat
nacetylglucosamin
sialic
acid
residu
therefor
linkag
pattern
sialic
acid
residu
analys
combin
salsa
posit
ion
mode
maldiqittof
ms
see
fig
spectrum
show
clearcut
peak
mz
na
fig
see
supplementari
fig
tabl
monoisotop
mz
na
valu
speci
without
salsa
calcul
basi
data
lcesim
ms
analys
found
fig
mass
differ
da
two
fraction
match
molecular
mass
two
ipa
singl
ipa
da
accordingli
conclud
glycan
carri
two
sialic
acid
residu
fig
tabl
supplementari
tabl
see
also
supplementari
tabl
final
case
speci
whose
characteris
requir
complic
analys
fig
see
also
fig
strial
glycan
origin
found
three
sialic
acid
residu
analys
three
differ
hplc
type
see
fig
appear
peak
mz
h
lcesim
spectra
supplementari
fig
subsequ
ms
analysi
detect
signal
mz
mz
predict
molecular
fragment
contain
pseudolewi
x
structur
ie
galnac
glcnac
fuc
supplementari
tabl
result
suggest
glycan
glycan
two
galnac
residu
howev
one
attach
sialic
acid
sulphat
group
remain
determin
h
mass
spectra
speci
see
also
supplementari
fig
left
panel
show
result
lcesi
ms
analysi
fraction
isol
reversedphas
hplc
see
fig
fragment
mz
h
next
subject
surgic
ms
assay
result
shown
right
panel
constitu
possibl
linkag
pattern
describ
sever
peak
panel
base
conclus
strial
glycan
sulphat
neuacgalnac
fig
observ
indic
molecular
mass
glycan
da
differ
mass
valu
obtain
two
seri
analys
explain
salsa
derivatis
precis
profil
glycan
carri
follow
experi
firstli
correspond
fraction
isol
via
reversedphas
hplc
subject
neg
ion
mode
maldiqittof
ms
without
salsa
analysi
identifi
signal
mz
mh
fig
origin
sampl
treat
salsa
assay
ms
type
visual
peak
mz
mh
fig
differ
da
molecular
mass
two
deproton
ion
mh
ident
molecular
mass
one
ipa
da
accordingli
speci
like
contain
sialic
acid
residu
fig
list
panel
amount
glycan
normalis
man
glcnac
ie
abund
among
glycan
speci
yellow
orang
blue
green
bar
indic
paucimannos
highmannos
complex
hybrid
type
glycan
structur
glycan
mark
black
bar
belong
either
complex
hybrid
type
see
text
data
glycan
deriv
tabl
supplementari
tabl
number
sialic
acid
residu
attach
glycan
also
shown
name
pie
graph
bd
describ
popul
paucimannos
yellow
highmannos
orang
complex
blue
hybrid
green
hybrid
complex
type
black
glycan
b
proport
sialyl
purpl
corefucosyl
red
glycan
c
respect
comparison
proport
four
glycan
type
see
b
also
shown
edg
graph
c
scientif
report
http
note
ms
spectrum
sampl
without
salsa
fig
two
peak
mz
mh
mz
mh
detect
former
like
repres
addit
na
origin
glycan
observ
peak
mz
mh
result
indic
speci
remain
deproton
even
acid
function
group
includ
glycan
neutralis
na
bind
word
glycan
multipl
acid
function
group
addit
even
though
sialic
acid
speci
neutralis
salsa
glycan
remain
deproton
form
mh
neg
ion
mode
maldiqittof
ms
fig
taken
togeth
speci
like
harbour
least
one
acid
function
group
differ
carboxyl
group
sialic
acid
context
ms
spectrum
obtain
sampl
without
salsa
fig
tabl
analysi
fraction
ms
assay
produc
multipl
signal
fig
fig
mz
valu
seem
repres
combin
mass
sulphat
group
da
galnac
altern
may
denot
glcnac
da
supplementari
tabl
logic
sulphat
group
attach
nonreduc
terminu
glycan
modif
case
strial
glycan
compris
neuacgalnac
glcnac
man
fucglcnac
fig
conclus
mean
inconsist
signal
detect
mz
esim
ms
spectra
fig
also
see
supplementari
profil
strial
nglycan
final
categoris
strial
nlink
glycan
accord
structur
profil
follow
major
vertebr
nglycan
categoris
three
group
ie
highmannos
complex
hybrid
type
common
core
glycan
chain
man
glcnac
type
differ
addit
sequenc
follow
firstli
highmannos
type
core
coupl
chain
variou
length
compos
pure
mannos
residu
secondli
complex
type
harbour
antenna
initi
nacetylglucosaminyltransferas
contain
differ
combin
monosaccharid
nacetylglucosamin
galactos
fucos
nacetylgalactosamin
sialic
acid
thirdli
hybrid
type
chain
mannos
ie
highmannosetyp
residu
complextyp
antenna
bound
core
addit
three
group
strial
glycan
belong
paucimannos
speci
man
glcnac
fuc
contain
four
mannos
antenna
structur
tabl
supplementari
tabl
type
common
invertebr
plant
recent
detect
vertebr
well
strial
nglycan
subject
categoris
present
fig
amount
normalis
amount
fraction
man
glcnac
ie
basi
characteris
obtain
proport
four
structur
type
among
glycan
illustr
fig
highmannos
type
abund
account
total
amount
strial
glycan
complex
hybrid
type
repres
respect
least
abund
varieti
paucimannos
type
repres
total
mention
galglcnachexnac
man
glcnac
unclear
whether
three
hexnac
residu
constitut
nonreduc
end
glcnac
galnac
tabl
supplementari
tabl
therefor
could
conclud
whether
glycan
belong
hybrid
complex
type
hand
seem
probabl
belong
complex
type
owe
identifi
monosaccharid
composit
nonreduc
end
see
tabl
supplementari
tabl
sialyl
occur
hybrid
complex
type
highmannos
paucimannos
type
stria
vasculari
total
amount
nglycan
singl
multipl
sialic
acid
residu
complex
hybrid
type
constitut
respect
fig
final
core
fucosyl
detect
total
amount
nglycan
ie
paucimannos
type
complex
type
hybrid
type
glycan
respect
fig
cochlear
stria
vasculari
essenti
hear
affin
lectin
type
concanavalin
ulex
europaeu
agglutinin
wheat
germ
agglutinin
although
observ
indic
tissu
express
differ
glycan
type
detail
profil
remain
unclear
present
studi
combin
differ
analyt
approach
detect
nlink
glycan
stria
vasculari
determin
rel
amount
fig
supplementari
tabl
process
identifi
complet
structur
strial
glycan
determin
partial
glycosid
linkag
pattern
full
monosaccharid
composit
glycan
fig
knowledg
detail
analysi
sugar
chain
stria
carri
date
method
compos
three
hplc
type
lcesim
rel
simpl
also
use
differ
sampl
analys
glycan
nonetheless
approach
seem
limit
particular
perfectli
distinguish
sialyl
linkag
isom
case
present
studi
addit
treat
sampl
salsa
clearli
distinguish
sialic
acid
residu
mass
spectrometri
fig
accordingli
workflow
combin
derivatis
ms
n
describ
fig
effect
sensit
procedur
characteris
glycan
structur
possibl
applic
glycan
librari
obtain
complement
studi
follow
mump
viru
infect
stria
vasculari
caus
deaf
vitro
experi
show
neuraminidas
viru
strongli
bind
unbranchedtyp
neuacgalglucos
neuacgalglcnac
sialyl
linkag
glycan
nevertheless
whether
protein
stria
vasculari
harbour
either
sugar
chain
remain
elus
list
strial
glycan
tabl
supplementari
tabl
latter
bind
site
includ
glycan
evid
reinforc
current
theori
rout
mump
infect
may
contribut
elucid
patholog
process
deaf
comparison
strial
glycan
structur
shown
studi
differ
experiment
result
may
expand
repertoir
use
librari
analysi
glycan
conclud
function
group
galnacglcnac
sulphat
group
fig
supplementari
fig
nevertheless
possibl
phosphoryl
instead
sulphat
rule
complet
oglycan
lacdinac
compos
two
hexnac
residu
phosphoryl
modif
may
identifi
hexnac
nglycan
studi
although
methodolog
shown
work
effect
analys
glycan
structur
sever
limit
first
issu
relat
liber
sugar
chain
glycoprotein
see
method
anhydr
hydrazin
employ
experi
extract
diverg
glycan
regardless
structur
protein
type
compar
enzym
includ
peptid
nglycosidas
f
nevertheless
hydrazinolysi
cleav
acyl
group
monosaccharid
constitut
glycan
therefor
renacetyl
sampl
acet
anhydrid
procedur
modif
also
affect
sialic
acid
residu
prevent
us
determin
individu
type
nacetyl
nglycolyl
oacetyl
deriv
second
limit
lie
procedur
purif
strial
glycan
trifluoroacet
acid
commonli
use
elut
acid
glycan
graphit
carbon
cartridg
load
sampl
reagent
strongli
acid
eluat
next
concentr
reason
increas
acidif
may
degrad
sugar
chain
studi
amount
tissu
stria
vasculari
expect
small
see
fig
therefor
sampl
process
vacuum
concentr
avoid
excess
acidif
ad
trifluoroacet
acid
instead
ammonium
acet
elut
buffer
final
concentr
mm
describ
literatur
see
method
noteworthi
increas
salt
concentr
acceler
releas
numer
glycan
cartridg
may
ineffect
collect
highli
acid
type
thirdli
standard
glycan
use
primarili
human
zebrafish
type
extrapol
glycan
data
rat
strial
glycan
address
care
moreov
present
fig
structur
strial
nglycan
could
complet
determin
mean
procedur
complet
resolv
issu
analys
sampl
treat
multipl
time
differ
exoglycosidas
mass
spectrometri
hplc
may
use
seri
assay
would
requir
consider
amount
sampl
therefor
seri
incorpor
workflow
analysi
glycan
stria
vasculari
tini
tissu
see
fig
context
experi
may
necessari
valid
procedur
isol
stria
vasculari
anim
experi
conduct
complianc
protocol
review
institut
anim
care
use
committe
approv
presid
niigata
univers
niigata
univ
re
compliant
arriv
guidelin
male
bnssnsic
rat
week
old
g
slc
hamamatsu
japan
use
rat
total
anim
anaesthetis
intraperiton
inject
sodium
pentobarbit
ml
per
rat
nembut
abbott
il
usa
deep
anaesthesia
confirm
toe
pinch
corneal
reflex
respiratori
rate
rat
heart
surgic
expos
cold
salin
ml
infus
system
left
ventricl
drainag
right
atrium
cochlea
dissect
tempor
bone
fig
stria
vasculari
spiral
ligament
isol
stereomicroscop
follow
firstli
cochlea
sagitt
divid
use
sharp
scalpel
boni
later
wall
contain
stria
vasculari
spiral
ligament
manual
separ
organ
corti
cochlear
axi
fine
tweezer
fig
secondli
later
cochlear
wall
consist
stria
ligament
detach
boni
wall
stria
identifi
brown
pigment
intermedi
cell
fig
care
peel
away
ligament
needl
fig
thirdli
isol
tissu
gentli
wash
standard
solut
five
eight
piec
stria
vasculari
ligament
length
obtain
one
cochlea
sampl
respect
tissu
cochlea
collect
ml
microtub
centrifug
g
min
tomi
tokyo
japan
remov
supernat
sampl
frozen
liquid
nitrogen
store
use
qpcr
analys
totalrna
sampl
extract
stria
vasculari
spiral
ligament
isol
cochlea
use
nucleospin
rna
xs
takara
bio
otsu
japan
concentr
qualiti
rna
estim
bioanalyz
agil
santa
clara
ca
usa
sampl
whose
rna
integr
encod
barttin
claudin
respect
compar
stria
vasculari
spiral
ligament
primer
sequenc
describ
earlier
work
experi
conduct
duplic
quantit
data
pcr
set
primer
obtain
refer
intern
control
gene
glyceraldehyd
dehydrogenas
gapdh
genbank
access
cdna
templat
result
ng
total
rna
use
assess
express
bsnd
ng
total
rna
test
gapdh
seri
assay
carri
three
time
differ
batch
cochlea
sampl
cochlea
rat
analys
total
gene
express
level
display
mean
se
n
differ
stria
vasculari
spiral
ligament
evalu
twotail
student
test
prepar
pyridylamin
glycan
stria
vasculari
nglycan
liber
strial
glycoprotein
hydrazinolysi
describ
previous
piec
strial
tissu
excis
cochlea
rat
store
separ
tube
combin
one
tube
next
sampl
lyophilis
heat
h
ml
anhydr
hydrazin
tokyo
chemic
industri
tokyo
japan
remov
reagent
repeat
evapor
glycan
renacetyl
acet
anhydrid
satur
sodium
bicarbon
solut
subsequ
desalt
pass
dowex
h
cation
exchang
dow
chemic
midland
mi
usa
sampl
lyophilis
heat
min
pyridylamin
reagent
reagent
prepar
dissolv
mg
acet
acid
final
heat
min
reduc
reagent
mixtur
dimethylamin
borat
mg
acet
acid
doubledistil
water
process
glycan
tag
fluorophor
pyridylamin
pa
glycan
reaction
mixtur
purifi
describ
elsewher
reaction
mixtur
dilut
ml
water
extract
twice
use
ml
phenol
chloroform
vv
remov
excess
reagent
contamin
water
layer
contain
paglycan
purifi
gel
filtrat
column
cm
tskgel
toyopearl
tosoh
tokyo
japan
equilibr
mm
ammonium
acet
ph
load
sampl
eluat
ml
collect
paglycan
fraction
paglycan
purifi
use
graphit
carbon
cartridg
glpak
carbograph
mg
gl
scienc
ltd
tokyo
japan
salt
concentr
glycan
mixtur
adjust
mm
ammonium
acet
ph
mixtur
load
onto
cartridg
wash
ml
mm
ammonium
acet
ph
glycan
elut
ml
acetonitril
ammonium
acet
buffer
eluat
concentr
mean
vacuum
concentr
dri
lyophilis
sampl
prepar
describ
perform
accord
mirag
guidelin
hplc
three
type
hplc
carri
use
water
allianc
water
separ
modul
fluoresc
detector
water
milfold
accord
mirag
guidelin
detail
inform
includ
paramet
set
describ
firstli
lyophilis
strial
pa
glycan
dissolv
ultrapur
water
analys
flow
rate
mlmin
anion
exchang
hplc
combin
tskgel
column
cm
tosoh
tokyo
japan
column
equilibr
mm
aqueou
ammonia
ph
sampl
inject
column
concentr
ammonium
acet
increas
linearli
time
point
min
elev
follow
min
paglycan
detect
fluoresc
spectrophotomet
excit
wavelength
nm
emiss
wavelength
nm
procedur
nglycan
separ
accord
number
attach
sialic
acid
residu
ie
fraction
n
see
fig
result
section
secondli
fraction
n
subject
reversedphas
hplc
involv
cosmosil
column
cm
nacalai
tesqu
kyoto
japan
flow
rate
sampl
mlmin
column
equilibr
mm
triethylamin
acet
ph
contain
inject
sampl
concentr
increas
linearli
min
neg
charg
sialic
acid
residu
interfer
separ
sampl
reversedphas
hplc
therefor
prepar
neutralis
triethylamin
ionpair
reagent
posit
charg
hydrophob
moieti
treatment
sharpen
elut
profil
acid
nglycan
paglycan
detect
excit
wavelength
nm
emiss
wavelength
nm
area
individu
peak
measur
separ
abund
speci
peak
whose
area
exceed
consid
signific
thu
fraction
subject
next
analysi
thirdli
sampl
process
size
fraction
hplc
involv
tsk
gel
amid
column
cm
tosoh
tokyo
japan
flow
rate
mlmin
column
equilibr
mm
ammonium
format
ph
contain
acetonitril
sampl
inject
acetonitril
concentr
decreas
linearli
min
next
min
final
subsequ
min
paglycan
detect
use
fluoresc
spectrophotomet
excit
wavelength
nm
emiss
wavelength
nm
peak
area
glycan
obtain
hplc
determin
follow
multipl
subfract
extract
fraction
reversedphas
hplc
area
proport
subfract
calcul
area
origin
fraction
multipli
proport
determin
area
subfract
glycan
whose
rel
amount
scientif
report
http
exceed
consid
signific
speci
satisfi
criterion
subject
lcesim
ms
see
fig
tabl
supplementari
tabl
glycan
elut
time
obtain
reversedphas
hplc
convert
r
stria
mean
reversedphas
scale
obtain
size
fraction
hplc
convert
stria
glucos
unit
describ
elsewher
lcesim
ms
analysi
massspectrometr
analysi
paglycan
perform
positiveion
mode
esim
ltq
xl
linear
ion
trap
mass
spectromet
coupl
dionex
hplc
system
thermo
scientif
san
jose
ca
fraction
isol
reversedphas
hplc
trap
hypercarb
guard
cartridg
column
mm
thermo
scientif
waltham
enrich
separ
contamin
sampl
elut
vv
formic
acid
water
formic
acid
acetonitril
flow
rate
gradient
condit
vari
differ
sampl
ms
analys
paglycan
carri
collisioninduc
dissoci
datadepend
mode
manual
select
parent
ion
isol
peak
intens
extract
mass
softwar
ver
shimadzu
kyoto
japan
ms
ms
spectra
display
supplementari
fig
sampl
prepar
massspectrometr
analys
describ
perform
accord
mirag
guidelin
detail
hplc
ms
ms
set
given
supplementari
tabl
salsa
multipl
maldiqittof
mass
spectrometri
ms
n
analysi
strial
paglycan
fraction
obtain
reversedphas
hplc
desalt
mean
stagetip
carbon
compos
empor
spe
carbon
disk
sigmaaldrich
st
loui
mo
solvent
remov
vacuo
glycan
includ
dri
sampl
derivatis
linkagespecif
manner
alkylamid
solut
contain
ipa
sampl
dri
redissolv
ultrapur
steril
water
solut
deposit
focu
maldi
plate
hudson
surfac
technolog
inc
old
tappan
nj
mix
matrix
solut
composit
solut
describ
supplementari
tabl
plate
place
heat
block
min
acceler
solvent
evapor
onplat
paglycan
analys
maldiqittof
ms
aximareson
shimadzukrato
manchest
uk
posit
neg
ion
mode
ms
n
analys
conduct
collisioninduc
dissoci
manual
select
parent
ion
isol
peak
intens
extract
use
shimadzu
biotech
launchpad
ver
krato
analyt
ltd
manchest
uk
note
glycan
detect
sole
type
hplc
analys
found
compos
two
speci
ie
procedur
combin
salsa
posit
ion
mode
maldim
tabl
supplementari
fig
tabl
rel
amount
two
speci
calcul
via
follow
three
step
firstli
usual
detect
result
mass
spectrometri
experi
care
observ
reveal
salsa
derivatis
glycan
posit
ion
mode
maldiqittof
ms
compos
multipl
isotop
peak
peak
within
da
mz
valu
onset
initi
peak
taken
signific
signal
data
point
signific
peak
analys
total
peak
intens
obtain
see
maldim
total
peak
intens
supplementari
tabl
secondli
use
valu
proport
glycan
ie
parent
fraction
speci
calcul
final
rel
amount
glycan
determin
multipli
proport
parent
amount
normalis
procedur
rel
amount
speci
calcul
tabl
supplementari
tabl
final
one
glycan
ms
n
analys
appli
fig
supplementari
fig
tabl
sampl
prepar
mass
spectrometri
describ
carri
accord
mirag
guidelin
inform
ms
ms
n
set
shown
supplementari
tabl
data
gener
analys
studi
includ
publish
articl
avail
correspond
author
reason
request
